Lupin gains on receiving tentative approval for generic Paxil CR tablets

26 Aug 2016 Evaluate

Lupin is currently trading at Rs 1527.35, up by 4.75 points or 0.31% from its previous closing of Rs 1522.60 on the BSE.

The scrip opened at Rs 1532.00 and has touched a high and low of Rs 1541.00 and Rs 1518.00 respectively. So far 94533 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs 1294.05 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs. 1599.00 and Rs 1505.00 respectively. The current market cap of the company is Rs 68964.03 crore.

The promoters holding in the company stood at 46.76%, while Institutions and Non-Institutions held 42.40% and 10.83% respectively.

Lupin has received tentative approval for its Paroxetine Extended-Release Tablets USP, 12.5 mg, 25 mg and 37.5 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Apotex Technologies, Inc.’s Paxil CR Tablets, 12.5 mg, 25 mg and 37.5 mg. As per IMS MAT June 2016, Paxil CR had US sales of $127.4 million.

Lupin’s Paroxetine Extended-Release Tablets USP, 12.5 mg, 25 mg and 37.5 mg are the AB rated generic equivalent of Apotex Technologies, Inc.’s Paxil CR Tablets, 12.5 mg, 25 mg and 37.5 mg. It is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

 

 

Lupin Share Price

2125.70 7.45 (0.35%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×